$BPTH
BIO-PATH HOLDINGS, INC. Stock $bpth

$bpth Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000114420417057782 Filed on November 09, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q4
Revenue	$40.00K	$0.00	$13.00K
YoY Change	207.69%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$820.0K	$890.0K	$730.0K
YoY Change	12.33%	30.88%	23.73%
% of Gross Profit
Research & Development	$1.390M	$1.583M	$950.0K
YoY Change	46.32%	-31.56%	9.2%
% of Gross Profit
Depreciation & Amortization	$100.0K	$120.0K	$50.00K
YoY Change	100.0%	140.0%	0.0%
% of Gross Profit
Operating Expenses	$2.210M	$2.476M	$1.681M
YoY Change	31.47%	-17.3%	14.9%
Operating Profit		-$2.476M	-$1.668M
YoY Change		-17.3%	14.01%
Interest Expense	$0.00	$0.00	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$2.000K	$297.0K
YoY Change	-100.0%	-99.86%	5840.0%
Pretax Income	-$2.170M	-$2.470M	-$1.370M
YoY Change	58.39%	57.32%	-6.16%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$2.170M	-$2.474M	-$1.371M
YoY Change	58.28%	57.58%	-5.97%
Net Earnings / Revenue	-5425.0%		-10546.15%
Basic Earnings Per Share
Diluted Earnings Per Share	-$4.019M	-$4.940M	-$2.854M
COMMON SHARES
Basic Shares Outstanding	113.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.970M	$4.620M	$9.380M
YoY Change	-36.35%	-59.12%	5.99%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$353.0K	$1.160M	$902.0K
YoY Change	-60.86%	4.5%	403.91%
Inventory
Prepaid Expenses	$1.117M	$653.0K	$376.0K
Receivables
Other Receivables
Total Short-Term Assets	$7.435M	$5.790M	$10.65M
YoY Change	-30.21%	-53.34%	11.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$654.0K	$720.0K	$614.0K
YoY Change	6.51%	990.91%	752.78%
Goodwill
YoY Change
Intangibles	$769.0K	$809.0K	$929.0K
YoY Change	-17.22%	-16.51%	-14.77%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.423M	$1.530M	$1.543M
YoY Change	-7.78%	48.54%	32.79%
TOTAL ASSETS
Total Short-Term Assets	$7.435M	$5.790M	$10.65M
Total Long-Term Assets	$1.423M	$1.530M	$1.543M
Total Assets	$8.858M	$7.320M	$12.20M
YoY Change	-27.37%	-45.54%	13.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$52.00K	$120.0K	$69.00K
YoY Change	-24.64%	0.0%	27.78%
Accrued Expenses	$739.0K	$630.0K	$969.0K
YoY Change	-23.74%	-16.0%	9.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$791.0K	$767.0K	$1.050M
YoY Change	-24.67%	-11.84%	12.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$2.910M
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$2.910M
YoY Change	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$791.0K	$767.0K	$1.050M
Total Long-Term Liabilities	$0.00	$0.00	$2.910M
Total Liabilities	$791.0K	$767.0K	$3.956M
YoY Change	-80.01%	-81.15%	322.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.16M	-$36.99M	-$32.13M
YoY Change	21.86%		26.59%
Common Stock	$1.000K	$100.0K	$96.00K
YoY Change	-98.96%		6.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.067M	$6.549M	$8.240M
YoY Change
Total Liabilities & Shareholders Equity	$8.858M	$7.316M	$12.20M
YoY Change	-27.37%	-45.57%	13.4%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q4
OPERATING ACTIVITIES
Net Income	-$2.170M	-$2.474M	-$1.371M
YoY Change	58.28%	57.58%	-5.97%
Depreciation, Depletion And Amortization	$100.0K	$120.0K	$50.00K
YoY Change	100.0%	140.0%	0.0%
Cash From Operating Activities	-$2.230M	-$1.530M	-$1.610M
YoY Change	38.51%	-19.9%	61.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$310.0K
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$310.0K
YoY Change	-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.570M	-30.00K	0.000
YoY Change		-100.33%
NET CHANGE
Cash From Operating Activities	-2.230M	-1.530M	-1.610M
Cash From Investing Activities	0.000	0.000	-310.0K
Cash From Financing Activities	3.570M	-30.00K	0.000
Net Change In Cash	1.340M	-1.560M	-1.920M
YoY Change	-169.79%	-122.07%	92.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.230M	-$1.530M	-$1.610M
Capital Expenditures	$0.00	$0.00	-$310.0K
Free Cash Flow	-$2.230M	-$1.530M	-$1.300M
YoY Change	71.54%	-18.62%	30.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	653000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	376000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	12000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	12000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	767000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1050000	USD
CY2017Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2906000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	767000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	3956000	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	96000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	43439000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40278000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36990000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32134000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	6549000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	8240000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7316000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12196000	USD
CY2017Q3	us-gaap	Revenues Revenues	0	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1583000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	893000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	2476000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2476000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	100057000	shares
CY2016Q3	us-gaap	Revenues Revenues	0	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2313000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	681000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	2994000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2994000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1424000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-1570000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	95645000	shares
CY2017Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2016Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1420000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	999000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	708000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	279000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	94000	USD
CY2017Q3	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	2500000	USD
CY2016Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	2500000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1691000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1571000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6807000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	98096000	shares
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2474000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2374000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2287000	USD
	us-gaap	Operating Expenses OperatingExpenses	6797000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1428000	USD
CY2015Q4	us-gaap	Cash Cash	8854000	USD
	us-gaap	Operating Expenses OperatingExpenses	6807000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6797000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1420000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2708000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4089000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	91724000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-4856000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5379000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1941000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-440000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2016Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1038000	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2474000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1570000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5894000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5379000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	121000	USD
	us-gaap	Depreciation Depreciation	31000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-364000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	733000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-71000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6537000	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	2445000	USD
CY2016Q3	us-gaap	Cash Cash	11299000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	120000	USD
	us-gaap	Depreciation Depreciation	185000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	277000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-391000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-36000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5732000	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-4752000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	538000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	675000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	550000	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	175000	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1518000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1518000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9007000	USD
	bpth	Incremental Fair Value Of Warrant Liability Modification IncrementalFairValueOfWarrantLiabilityModification	797000	USD
	bpth	Incremental Fair Value Of Warrant Liability Modification IncrementalFairValueOfWarrantLiabilityModification	0	USD
CY2016Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5882352	shares
CY2016Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	9300000	USD
CY2017Q2	bpth	Class Of Warrant Or Right Exercisable Number ClassOfWarrantOrRightExercisableNumber	4411764	shares
CY2017Q2	bpth	Class Of Warrant Or Right Exercised Number ClassOfWarrantOrRightExercisedNumber	111764	shares
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	1000000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	100000	USD
CY2017Q3	us-gaap	Other Inventory OtherInventory	700000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	600000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7067000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6921000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6022000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	682000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.33
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.23
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.14
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.75
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6000	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1000000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2906000	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-2374000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-357000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	175000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3199000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1420000	USD
CY2016Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4600000	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	2400000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2900000	USD
CY2017Q3	bpth	Accrued Vacation And Bonus AccruedVacationAndBonus	300000	USD
CY2016Q4	bpth	Accrued Vacation And Bonus AccruedVacationAndBonus	400000	USD
CY2016Q4	bpth	Accrued License Maintenance Fee AccruedLicenseMaintenanceFee	100000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	100000	USD
CY2017Q3	bpth	Accrued Clinical And Preclinical AccruedClinicalAndPreclinical	200000	USD
CY2016Q4	bpth	Accrued Laboratory Expense AccruedLaboratoryExpense	200000	USD
CY2016Q4	bpth	Accrued Clinical And Preclinical AccruedClinicalAndPreclinical	200000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	100000	USD
CY2017Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	100000	USD
CY2016Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	100000	USD
CY2016Q4	us-gaap	Other Inventory OtherInventory	400000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	BIO-PATH HOLDINGS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001133818
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Accelerated Filer
	dei	Trading Symbol TradingSymbol	BPTH
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113390320	shares
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	720000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	614000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	809000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	929000	USD
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	4619000	USD
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100057000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	100057000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95645000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95645000	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9007000	USD
CY2017Q3	us-gaap	Prepaid Insurance PrepaidInsurance	100000	USD
CY2016Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3199000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0206	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.99	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.09	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.68
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	828000	shares
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	48000	USD
CY2017Q3	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	1800000	USD

Files In Submission

Name	View Source	Status
0001144204-17-057782-index-headers.html	Edgar Link	pending
0001144204-17-057782-index.html	Edgar Link	pending
0001144204-17-057782.txt	Edgar Link	pending
0001144204-17-057782-xbrl.zip	Edgar Link	pending
bpth-20170930.xml	Edgar Link	completed
bpth-20170930.xsd	Edgar Link	pending
bpth-20170930_cal.xml	Edgar Link	unprocessable
bpth-20170930_def.xml	Edgar Link	unprocessable
bpth-20170930_lab.xml	Edgar Link	unprocessable
bpth-20170930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv478242_10q.htm	Edgar Link	pending
tv478242_ex31.htm	Edgar Link	pending
tv478242_ex32.htm	Edgar Link	pending
tv478242_img1.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BPTH
BIO-PATH HOLDINGS, INC. Stock $bpth

2017 Q4 Form 10-Q Financial Statement

#000114420417057782 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BPTH BIO-PATH HOLDINGS, INC. Stock $bpth

2017 Q4 Form 10-Q Financial Statement

#000114420417057782 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BPTH
BIO-PATH HOLDINGS, INC. Stock $bpth